Sfondo Header
L'angolo del dottorino
Search the site... Advanced search
✖

Diseases of the aorta

Diseases of the aorta encompass conditions that change the structure, caliber, continuity or function of the body's main artery. Some progress slowly and are detected when the patient has no symptoms; others suddenly interrupt perfusion to vital organs or cause hemorrhage. Aneurysms, dissections, inflammatory processes, infections, atherosclerotic lesions and trauma share an anatomical location but have different causes, natural histories and treatments. The term aortopathy describes this group of abnormalities without, by itself, establishing an etiological diagnosis or level of urgency.

The aorta is not simply a conduit for blood ejected by the left ventricle. Its elastic wall stores part of the energy of systolic ejection and releases it during diastole, helping maintain peripheral flow between heartbeats. Continuity between the aortic root, valve and coronary ostia closely links proximal aortic diseases to cardiac function; relationships with cerebral, visceral, renal and spinal arteries explain why a lesion distant from the heart may manifest as stroke, abdominal pain, renal failure or limb deficits. Assessment must therefore consider the wall, lumen and perfused organs simultaneously.

No single prevalence estimate applies to all aortic diseases. Abdominal aneurysms are more frequent in older men and people with a smoking history, whereas thoracic forms include a substantial proportion of familial, syndromic and bicuspid aortic valve-associated disorders. Bicuspid aortic valve affects approximately 1–2% of the population and does not necessarily cause aortic dilatation in every carrier. Dissection is far less frequent than common atherosclerotic diseases, but its impact is amplified by mortality before hospital arrival: in the population-based Oxford Vascular Study, observed incidence was approximately six cases per 100,000 people per year. These estimates pertain to specific populations and methods, not universal values transferable to any setting.

One principle applies throughout the spectrum: severity cannot be inferred from a single measurement. An increased diameter must be interpreted in relation to segment, body size, etiology and growth; an aorta that is not markedly dilated may still dissect in certain hereditary diseases; an apparently localized abnormality may be part of more extensive vascular disease. The characterization of aortopathies arises from integrating these factors and precedes the choice between surveillance, drug treatment and intervention.

Functional anatomy and main disease types

The aortic root extends from the region of cusp insertion to the sinotubular junction and includes the sinuses of Valsalva, from which the right and left coronary arteries arise. Its geometry enables valve opening and leaflet coaptation during the cardiac cycle. When this geometry changes, aortic regurgitation may develop even without primary cusp disease. An aortic root aneurysm therefore has different implications from dilatation confined to the tubular ascending segment: treatment must consider both wall disease and valve competence, as well as reimplantation of the coronary ostia.

The ascending aorta continues into the arch, which gives rise to branches supplying the head and upper limbs. Beyond the left subclavian origin, the descending segment passes through the thorax and reaches the diaphragm; the abdominal segment supplies the major visceral and renal branches before iliac bifurcation. This continuity does not eliminate regional differences. Matrix composition, embryological origin of smooth muscle cells, elastin content and mechanical stresses vary along the vessel, contributing to nonrandom disease distributions. Feasibility of endovascular repair also depends on curvature, branching and segments in which a device can be securely anchored.

The aortic aneurysms are permanent dilatations associated with pathological wall remodeling. A general definition based on an increase of at least 50% over expected diameter is useful in many vascular regions but should not be rigidly applied to the root or ascending aorta, where clinical assessment also uses absolute and indexed limits. A threshold of 30 mm is commonly adopted in the abdominal aorta. A true aneurysm retains wall continuity, although the wall is abnormal; a pseudoaneurysm instead results from loss of continuity contained by surrounding tissues or residual structures. This distinction is fundamental because it changes interpretation of cause and risk.

In acute aortic syndromes, the central problem is wall damage that may progress rapidly. Dissection separates wall layers, creating a false lumen; intramural hematoma involves blood within the wall without the typical clearly recognizable perfused false lumen on the initial study; a penetrating atherosclerotic ulcer passes through the internal elastic lamina and extends into the media. These conditions may overlap or evolve into one another. The historical expression dissecting aneurysm can be misleading: dissection does not necessarily presuppose an aneurysm and is not equivalent to simple dilatation.

The genetic aortopathies include syndromic diseases and forms in which vascular abnormalities are the dominant clinical feature. Aortitis, by contrast, is an inflammatory process of the wall, immune-mediated or infectious, capable of causing thickening, stenosis, dilatation and rupture. Atheroma and mural thrombus act primarily through luminal surface involvement and embolization, whereas traumatic injuries result from external forces or, in iatrogenic forms, procedures. These categories are not mutually exclusive: a patient may have hereditary predisposition, hypertension and atherosclerosis, or a previously stable aneurysm complicated by infection.

Etiology, pathogenesis and pathophysiological consequences

Wall strength depends on interactions among elastic lamellae, collagen fibers, smooth muscle cells and extracellular matrix. Elastin favors reversible deformation at physiological pressures; collagen limits distension and contributes to strength as load increases. Muscle cells do more than contract: they sense stresses, organize the matrix and participate in its maintenance. Alteration of any one of these elements can therefore change the overall balance. Mechanotransduction, through connections among matrix, integrins and the cytoskeleton, links hemodynamic load to biological responses that preserve or impair the wall.

In certain conditions the cause can be identified. Pathogenic variants in genes encoding matrix components, contractile proteins or regulators of cellular signaling may predispose to aneurysm and dissection. Marfan syndrome is linked to FBN1; Loeys–Dietz syndrome involves different genes in the transforming growth factor beta pathway; vascular Ehlers–Danlos syndrome is associated with COL3A1. Nonsyndromic aortopathies may involve ACTA2, MYH11, MYLK and PRKG1, among others. Gene–disease associations must be documented and individual variants interpreted: a variant of uncertain significance is not equivalent to proof of a genetic cause.

In other patients, damage emerges from interactions between predisposition, aging and acquired factors. Hypertension increases wall loading and promotes aortic events, but does not automatically explain every aneurysm. Smoking is particularly strongly associated with abdominal aneurysm. Atherosclerosis, chronic inflammation, oxidative stress and proteolytic activity can contribute to remodeling, but an aneurysm is not simply a plaque that enlarges. Smooth muscle and matrix abnormalities are more prominent in the proximal thoracic aorta; inflammation, elastin loss and intraluminal thrombus are often more evident in the abdominal segment. These are biological tendencies, not rigid compartments.

Progression may be sustained by a cycle of injury and ineffective repair. Fragmentation of elastic fibers transfers load to other components; cells alter their phenotype, matrix production and protease secretion; cell loss further reduces the ability to maintain tissue. Matrix metalloproteinases and other proteolytic systems degrade structural components, while inflammatory mediators may amplify the process. However, involvement of a molecular pathway does not establish that pharmacologically blocking it provides clinical benefit. The failure of doxycycline to slow growth of small abdominal aneurysms in a randomized trial illustrates the gap that may exist between a plausible experimental rationale and a usable treatment.

When local strength becomes insufficient, the wall may dilate or separate along planes of weaker cohesion. In dissection, the false lumen may compress the true lumen or directly involve branch origins. Malperfusion may thus be dynamic, when the flap variably obstructs flow into a branch, or static, when dissection and thrombosis extend into the affected vessel. The outcome does not depend solely on aortic diameter: interruption of mesenteric flow may be immediately devastating even without extreme dilatation. Loss of outward wall continuity instead causes hemorrhage, with different consequences depending on the anatomical space involved.

Inflammatory diseases involve additional mechanisms. In large-vessel vasculitis, immune cells and inflammatory mediators damage the wall and alter its remodeling; fibrosis and intimal hyperplasia may narrow the lumen, while destruction of elastic components may favor aneurysm. In infectious aortitis, microbial colonization causes tissue destruction requiring antimicrobial treatment and often repair. Confusing these situations is particularly dangerous: immunosuppression may be necessary in vasculitis and harmful in an uncontrolled infection. Identifying the cause therefore remains integral to preventing complications.

Clinical manifestations: from history to physical examination

Assessment begins with the reason aortic disease is suspected. An incidental finding during ultrasound, tomography or MRI requires a different evaluation from sudden pain. In the former, location, previous measurements and even mild symptoms must be clarified; in the latter, recognizing a possible acute event is the priority. Absence of symptoms is common in chronic dilatation and does not rule out a significant lesion. Conversely, chest pain alone is not proof of aortic disease: its relationship to the aorta must be established by combining pain characteristics, predisposing factors and imaging.

For pain, clinicians investigate time of onset, how quickly it reached maximum intensity, initial location, any migration and associated symptoms. Sudden pain that is severe from onset, in the chest, back or abdomen, raises suspicion of an acute aortic syndrome, especially in someone with known aortic disease. A tearing description may be suggestive but is not required. Syncope, neurological deficits, limb weakness, dyspnea or abdominal pain may dominate presentation; some dissections produce little pain. History-taking that relies too heavily on a stereotyped description of pain may therefore miss clinically important presentations.

Chronic diseases also warrant assessment for symptoms of compression. A thoracic aneurysm may cause hoarseness through recurrent laryngeal nerve involvement, dysphagia through esophageal compression or respiratory symptoms through its relationship to the trachea and bronchi. Root dilatation with valvular regurgitation may primarily manifest as exertional dyspnea, palpitations or reduced functional capacity. An abdominal aneurysm may be felt as pulsation or a mass but is often clinically silent. New persistent pain in a patient with a known aneurysm warrants urgent reassessment, even if the prior diameter was below an elective intervention threshold.

Personal history covers hypertension and its control, smoking, previous cardiovascular procedures, bicuspid aortic valve, coarctation, trauma, recent infections and inflammatory conditions. Fever, weight loss, fatigue or persistent pain may point to an inflammatory or infectious process, but none is specific. Recent-onset headache, jaw claudication, visual disturbances and polymyalgic symptoms suggest giant cell arteritis; limb claudication and blood pressure differences may accompany large-vessel disease. Suspicion must remain proportionate to context rather than automatically attributing common nonspecific symptoms to the aorta.

The family history looks for aneurysms, dissections, premature sudden deaths and aortic procedures, ideally verifying diagnoses and documentation. Lack of a previously diagnosed relative does not exclude an inherited form because penetrance may be incomplete, expression variable or the variant newly arisen in the patient. Reproductive history and pregnancy plans are also relevant in women with aortopathy: increased circulatory load and wall changes may modify risk during gestation and postpartum.

Physical examination moves from vital signs to peripheral perfusion and cardiac consequences. Blood pressure, heart rate, consciousness, extremity temperature and, when indicated, pressure in both arms are assessed; pulses are compared, and an aortic regurgitation murmur sought. Pulmonary congestion, hypotension, pulse deficits or neurological changes may indicate complications. The abdomen is examined clinically, without using palpation to rule out an aneurysm. In stable forms, body proportions, skeletal abnormalities, skin features and other syndromic manifestations are sought. A normal examination, however, excludes neither chronic dilatation nor dissection: classical signs are valuable when present but insufficiently sensitive to reassure when absent.

Investigations, diagnosis and determination of extent

No single diagnostic criteria apply to the entire category of aortic diseases. The anatomical lesion must be identified, its extent and consequences determined, and its cause investigated. According to the ACC/AHA aortic disease guidelines, test selection depends primarily on clinical presentation and the region under study. In a stable patient, transthoracic echocardiography is a first-line reference for the root, visible ascending aorta, valve and left ventricle; abdominal ultrasound is suitable for detecting and following infrarenal aneurysms. Neither modality necessarily describes the whole aorta on its own.

The use of CT angiography provides rapid and detailed reconstruction of the lumen, wall, branches and relationships to surrounding structures. It is essential when an acute event is suspected and for planning many repairs. Electrocardiographic gating improves assessment of the root and ascending aorta by reducing motion artifacts that may mimic a flap. The protocol is tailored to the question: an unenhanced phase may reveal intramural blood, whereas the angiographic acquisition documents the lumina, branches and any bleeding. Extending the study beyond the apparently affected segment is often necessary to avoid underestimating the disease.

The use of magnetic resonance imaging enables anatomical and functional assessment without ionizing radiation and has an important role in surveillance of younger patients or those requiring repeated examinations. The option of using sequences without contrast is valuable in selected situations. Acquisition time, access and monitoring requirements may make it less suitable for unstable patients. Transesophageal echocardiography instead provides close assessment of much of the thoracic aorta, the valve and pericardial complications; it may be crucial at the bedside or in the operating room, despite less favorable visualization of certain segments and not always replacing mapping of the whole vessel.

The quality of the measurement is part of diagnosis. Diameter must be measured in appropriate planes perpendicular to the vessel axis, specifying location, cardiac phase and the convention used. Comparing measurements obtained with different techniques or planes may simulate nonexistent growth. Where possible, surveillance uses the same modality and directly comparable prior images. Dilatation is interpreted against age and body size; Z-scores are especially important in children, whereas indices relative to height or body surface area may complement absolute diameter in specific adult settings.

When an acute aortic syndrome is suspected, electrocardiography, troponin, complete blood count, creatinine and other investigations help assess alternative diagnoses and organ damage but do not replace aortic imaging. A negative D-dimer may be useful in validated pathways for patients with low clinical probability, such as those studied using the Aortic Dissection Detection Risk Score; it is not a standalone rule-out test when suspicion is high. Neither a normal chest X-ray nor a positive troponin resolves the question: the former does not exclude dissection, and the latter may reflect coronary involvement from the aortic disease itself.

After anatomical confirmation, further investigations focus on findings that may change management and prognosis. Familial or syndromic phenotype prompts genetic counseling and screening of relatives; fever, inflammatory markers and wall findings may call for blood cultures, rheumatological evaluation or metabolic imaging. Fluorodeoxyglucose PET can help assess inflammatory activity, but uptake alone does not identify a specific etiology. Hereditary diseases and some vasculitides have their own diagnostic or classification systems, which must not be applied indiscriminately to every aortopathy. The final report must clarify not only how wide the aorta is, but also which segments and branches are affected, whether there are signs of instability and which organs are experiencing consequences.

Treatment, surveillance and prognosis

The first treatment decision concerns how much time is available. Stable disease allows scheduled assessment; proximal dissection, rupture or malperfusion calls for an urgent pathway. Care is organized around a team with cardiology, cardiac surgery, vascular surgery, radiology and anesthesiology expertise, supplemented as needed by genetics, rheumatology and infectious diseases. The aim is not to apply the same solution to all lesions but to balance natural-history risk, procedural risk, expected duration of benefit and the patient's condition.

In chronic forms, blood pressure control reduces wall stress and is a fundamental component of care. Smoking cessation and treatment of other cardiovascular risk factors address overall risk, particularly important in atherosclerotic forms. Beta-blockers and angiotensin receptor blockers have a documented role in specific aortopathies, especially Marfan syndrome, but results in one disease do not automatically establish the same benefit in all others. Statins, antiplatelet drugs and anticoagulants have distinct indications: an aneurysm alone is not a universal reason to start anticoagulation.

Surveillance is not passive waiting. The interval between examinations depends on diameter, location, etiology, growth, proximity to a possible surgical indication and the quality of previous measurements. An unexpected change must be confirmed through rigorous comparison, but new symptoms or signs of instability require immediate reassessment. Intervention decisions also consider family history of dissection, genetic variant, associated valve disease, pregnancy plans and body size. A numerical threshold is useful only within the context in which it was defined; it is not a biological boundary below which risk disappears.

Open surgery replaces the diseased segment with a graft and, where necessary, reconstructs branches or treats the valve. Root surgery may involve a valve-sparing procedure or combined replacement depending on anatomy and center expertise. Endovascular repair excludes the lesion from flow with a stent graft introduced through an artery. It is particularly important in numerous diseases of the descending and abdominal aorta, but requires suitable anatomy, adequate access and subsequent surveillance. The two approaches have different advantages and limitations; lower initial invasiveness does not mean no late risk.

A type A dissection, involving the ascending aorta, generally requires emergency surgical repair. In type B dissection, rupture, organ ischemia or other complications favor intervention, often endovascular when feasible; uncomplicated forms require medical therapy and surveillance, with selection of patients in whom preventive intervention may offer benefit. Initial treatment of acute syndromes aims to reduce pain and hemodynamic impulse without impairing perfusion while definitive management is arranged. Hemorrhage with shock cannot be managed simply by increasing antihypertensive drugs.

Immune-mediated aortitis requires inflammation treatment tailored to the disease, whereas infectious forms require targeted antibiotics and assessment for repair. For mural thrombus, choosing among anticoagulation, endovascular treatment and surgery depends on mobility, location, embolization and associated conditions. Physical activity is best individualized, avoiding efforts that produce marked blood pressure surges in patients at risk. Before pregnancy, specialist assessment of the entire aortic and therapeutic profile is indicated. Prognosis improves when disease is recognized before an emergency, but remains related to its cause and continuity of follow-up: effective repair of the most dangerous segment does not necessarily eliminate predisposition in the rest of the aorta.

Complications and their recognition over time

Complication rates vary markedly across diseases and stages, so there is no single ranking. For monitored dilatations, the most common concern to track is diameter progression, which may ultimately lead to an indication for preventive repair. Enlargement is not always steady, and stability across a few examinations does not guarantee permanent stability. After dissection, a residual false lumen may maintain enough pressure to cause late dilatation; after segment replacement, other parts of the native aorta may continue to change.

Dissection and aortic rupture are the most feared complications because they can rapidly become fatal. Proximal aortic rupture into the pericardium causes hemopericardium and tamponade, impairing cardiac filling; thoracic rupture may cause hemothorax or mediastinal hematoma; abdominal rupture causes retroperitoneal or intraperitoneal hemorrhage. Initially contained bleeding may deteriorate suddenly. Acute pain, syncope, hypotension or loss of consciousness in a patient with aortic disease must therefore be regarded as possible manifestations of instability pending proper evaluation.

Organ ischemia results from branch obstruction, embolization or reduced systemic output. Coronary involvement can cause myocardial ischemia and arrhythmias; cerebral vessel involvement can cause stroke; reduced mesenteric flow can cause intestinal necrosis; renal involvement can cause acute injury and hypertension; impairment of the spinal vascular network can cause motor deficits up to paraplegia. An important difference separates imaging evidence that a branch is involved from the clinical malperfusion syndrome: the latter entails tissue and functional consequences that crucially influence strategy and prognosis.

Cardiac consequences mainly include aortic regurgitation. In chronic root dilatation, failure of leaflet coaptation causes left ventricular volume overload and progressive remodeling; in acute dissection, severe regurgitation may arise suddenly and cause pulmonary edema or shock. Compressive complications often evolve more gradually. Large aneurysms may compromise respiratory, esophageal or venous structures; rarely, abnormal communications form with the airways or digestive tract, with hemorrhage and possible infection. Even apparently limited bleeding may precede a catastrophic event.

Aortic atheroma and mural thrombus can release embolic material. Thrombotic embolization occludes arteries of varying caliber; cholesterol crystals from complex plaques may affect the microcirculation and produce a multisystem disorder. Recognizing the mechanism is essential because not all emboli are treated the same way. In aortic infection, injury may also spread to surrounding tissues, causing pseudoaneurysms, sepsis or fistulas: monitoring diameter alone without treating infection does not protect against these developments.

Finally, even successful repair requires monitoring for potential procedural complications. Surgery may be followed by bleeding, ischemia, infection or anastomotic problems; endovascular treatment requires checking for persistent flow in the aneurysm sac, migration, loss of seal, branch occlusion or progression in adjacent segments. Follow-up is adapted to the procedure and findings, with attention to renal function and cumulative exposure from examinations. Long-term protection comes from combining lesion treatment, control of disease determinants and prompt recognition of clinical changes.

Bibliography
  1. Isselbacher EM et al. 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Journal of the American College of Cardiology. 2022;80(24):e223–e393.
  2. Mazzolai L et al. 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases. European Heart Journal. 2024;45(36):3538–3700.
  3. Czerny M et al. EACTS/STS Guidelines for diagnosing and treating acute and chronic syndromes of the aortic organ. European Journal of Cardio-Thoracic Surgery. 2024;65(2):ezad426.
  4. Wanhainen A et al. Editor’s Choice – European Society for Vascular Surgery (ESVS) 2024 Clinical Practice Guidelines on the Management of Abdominal Aorto-Iliac Artery Aneurysms. European Journal of Vascular and Endovascular Surgery. 2024;67(2):192–331.
  5. Bossone E et al. Epidemiology and management of aortic disease: aortic aneurysms and acute aortic syndromes. Nature Reviews Cardiology. 2021;18(5):331–348.
  6. Howard DPJ et al. Population-based study of incidence and outcome of acute aortic dissection and premorbid risk factor control: 10-year results from the Oxford Vascular Study. Circulation. 2013;127(20):2031–2037.
  7. Humphrey JD et al. Role of mechanotransduction in vascular biology: focus on thoracic aortic aneurysms and dissections. Circulation Research. 2015;116(8):1448–1461.
  8. Golledge J. Abdominal aortic aneurysm: update on pathogenesis and medical treatments. Nature Reviews Cardiology. 2019;16(4):225–242.
  9. Nienaber CA et al. Aortic dissection. Nature Reviews Disease Primers. 2016;2:16053.
  10. Renard M et al. Clinical Validity of Genes for Heritable Thoracic Aortic Aneurysm and Dissection. Journal of the American College of Cardiology. 2018;72(6):605–615.
  11. Rodríguez-Palomares JF et al. Mechanisms of Aortic Dilation in Patients With Bicuspid Aortic Valve: JACC State-of-the-Art Review. Journal of the American College of Cardiology. 2023;82(5):448–464.
  12. Evangelista A et al. Multimodality imaging in thoracic aortic diseases: a clinical consensus statement from the European Association of Cardiovascular Imaging and the European Society of Cardiology working group on aorta and peripheral vascular diseases. European Heart Journal – Cardiovascular Imaging. 2023;24(5):e65–e85.
  13. Nazerian P et al. Diagnostic Accuracy of the Aortic Dissection Detection Risk Score Plus D-Dimer for Acute Aortic Syndromes: The ADvISED Prospective Multicenter Study. Circulation. 2018;137(3):250–258.
  14. Pitcher A et al. Angiotensin receptor blockers and β blockers in Marfan syndrome: an individual patient data meta-analysis of randomised trials. The Lancet. 2022;400(10355):822–831.
  15. Baxter BT et al. Effect of Doxycycline on Aneurysm Growth Among Patients With Small Infrarenal Abdominal Aortic Aneurysms: A Randomized Clinical Trial. JAMA. 2020;323(20):2029–2038.
  16. Dejaco C et al. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice: 2023 update. Annals of the Rheumatic Diseases. 2024;83(6):741–751.
  17. Maz M et al. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis. Arthritis & Rheumatology. 2021;73(8):1349–1365.
  18. Wilson WR et al. Vascular Graft Infections, Mycotic Aneurysms, and Endovascular Infections: A Scientific Statement From the American Heart Association. Circulation. 2016;134(20):e412–e460.
  19. Fayad ZY et al. Aortic mural thrombus in the normal or minimally atherosclerotic aorta. Annals of Vascular Surgery. 2013;27(3):282–290.
  20. De Backer J et al. 2025 ESC Guidelines for the management of cardiovascular disease and pregnancy. European Heart Journal. 2025;46(43):4462–4568.

Informational notice: the information contained on this page is provided solely for informational and educational purposes and does not replace the advice, diagnosis or treatment provided by a physician. If needed, always consult a qualified healthcare professional.

Artificial intelligence transparency: this page was created with the support of artificial intelligence tools, used to assist in the production and processing of its content.